Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cysteine | 3 | 2018 | 112 | 0.830 |
Why?
|
| Hippocampus | 11 | 2021 | 471 | 0.830 |
Why?
|
| Dimethyl Fumarate | 2 | 2018 | 2 | 0.820 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 110 | 0.780 |
Why?
|
| Tubulin | 2 | 2018 | 60 | 0.660 |
Why?
|
| Fumarates | 5 | 2019 | 28 | 0.630 |
Why?
|
| Astrocytes | 1 | 2018 | 270 | 0.560 |
Why?
|
| Leigh Disease | 1 | 2015 | 3 | 0.550 |
Why?
|
| Electron Transport Complex I | 1 | 2015 | 20 | 0.550 |
Why?
|
| Succinates | 1 | 2015 | 9 | 0.550 |
Why?
|
| Thiazepines | 3 | 2012 | 14 | 0.540 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 290 | 0.530 |
Why?
|
| Amygdala | 3 | 2012 | 159 | 0.530 |
Why?
|
| Neurons | 3 | 2018 | 881 | 0.520 |
Why?
|
| Succinic Acid | 1 | 2014 | 9 | 0.510 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2012 | 45 | 0.470 |
Why?
|
| Proteomics | 1 | 2015 | 246 | 0.460 |
Why?
|
| Stress, Psychological | 5 | 2012 | 824 | 0.460 |
Why?
|
| Glutamic Acid | 2 | 2012 | 332 | 0.410 |
Why?
|
| Insulin | 4 | 2016 | 617 | 0.380 |
Why?
|
| Rats | 15 | 2021 | 5300 | 0.370 |
Why?
|
| 3T3-L1 Cells | 4 | 2018 | 30 | 0.370 |
Why?
|
| Receptor, Insulin | 5 | 2015 | 71 | 0.340 |
Why?
|
| Corticosterone | 3 | 2010 | 51 | 0.340 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2017 | 195 | 0.340 |
Why?
|
| Glucose | 5 | 2017 | 307 | 0.340 |
Why?
|
| Animals | 23 | 2021 | 20877 | 0.330 |
Why?
|
| Membrane Proteins | 1 | 2012 | 617 | 0.320 |
Why?
|
| Adipocytes | 3 | 2019 | 88 | 0.310 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2007 | 34 | 0.300 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 1293 | 0.290 |
Why?
|
| Mitochondria | 3 | 2017 | 643 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2015 | 2083 | 0.260 |
Why?
|
| Mice | 8 | 2018 | 8472 | 0.260 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 54 | 0.250 |
Why?
|
| Stress, Physiological | 1 | 2004 | 215 | 0.220 |
Why?
|
| Leptin | 3 | 2011 | 80 | 0.210 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2019 | 99 | 0.200 |
Why?
|
| Citalopram | 1 | 2021 | 29 | 0.200 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 81 | 0.190 |
Why?
|
| Neuronal Plasticity | 2 | 2015 | 274 | 0.180 |
Why?
|
| Obesity | 4 | 2021 | 1074 | 0.180 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 2550 | 0.180 |
Why?
|
| Insulin Resistance | 2 | 2015 | 241 | 0.180 |
Why?
|
| Citric Acid Cycle | 2 | 2017 | 15 | 0.180 |
Why?
|
| Adipogenesis | 2 | 2016 | 17 | 0.170 |
Why?
|
| Cofilin 1 | 1 | 2018 | 6 | 0.170 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2017 | 139 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 146 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 284 | 0.160 |
Why?
|
| Biological Assay | 1 | 2018 | 88 | 0.160 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2018 | 68 | 0.150 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cannabinoids | 1 | 2018 | 90 | 0.150 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2017 | 27 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 284 | 0.150 |
Why?
|
| Adipocytes, Brown | 1 | 2016 | 1 | 0.140 |
Why?
|
| Down-Regulation | 3 | 2016 | 447 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2018 | 2688 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2673 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 103 | 0.140 |
Why?
|
| Brain Stem | 1 | 2015 | 46 | 0.140 |
Why?
|
| Spatial Learning | 1 | 2015 | 12 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2014 | 7 | 0.130 |
Why?
|
| Microdialysis | 2 | 2012 | 147 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 244 | 0.130 |
Why?
|
| Protein Transport | 2 | 2007 | 280 | 0.130 |
Why?
|
| Polymerization | 1 | 2014 | 17 | 0.130 |
Why?
|
| Analysis of Variance | 3 | 2012 | 1039 | 0.130 |
Why?
|
| Synaptophysin | 2 | 2004 | 16 | 0.130 |
Why?
|
| Culture Media | 1 | 2014 | 155 | 0.120 |
Why?
|
| Hypothalamus | 2 | 2011 | 78 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 230 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2014 | 1085 | 0.120 |
Why?
|
| Cattle | 1 | 2014 | 475 | 0.120 |
Why?
|
| Transcription Factor CHOP | 3 | 2019 | 28 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2014 | 221 | 0.110 |
Why?
|
| Time Factors | 3 | 2012 | 4655 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2014 | 222 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 132 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1692 | 0.100 |
Why?
|
| Brain | 2 | 2014 | 2175 | 0.100 |
Why?
|
| Food Deprivation | 1 | 2010 | 22 | 0.100 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 57 | 0.100 |
Why?
|
| Long-Term Potentiation | 1 | 2010 | 53 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1173 | 0.090 |
Why?
|
| Male | 11 | 2015 | 37281 | 0.090 |
Why?
|
| Aging | 2 | 2008 | 911 | 0.090 |
Why?
|
| Oxidative Stress | 3 | 2019 | 718 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2014 | 902 | 0.090 |
Why?
|
| Autoradiography | 2 | 2010 | 94 | 0.090 |
Why?
|
| Cell Membrane | 2 | 2007 | 523 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2006 | 1663 | 0.080 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2006 | 26 | 0.070 |
Why?
|
| Receptors, AMPA | 3 | 2015 | 99 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 124 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 216 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2008 | 342 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2005 | 954 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2006 | 291 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2005 | 111 | 0.060 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2004 | 6 | 0.060 |
Why?
|
| Microsomes | 1 | 2004 | 31 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 770 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 164 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 1174 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2015 | 1199 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 201 | 0.060 |
Why?
|
| Amphetamine | 1 | 2004 | 77 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 529 | 0.060 |
Why?
|
| Depression | 1 | 2011 | 942 | 0.060 |
Why?
|
| Membrane Potentials | 2 | 2018 | 200 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2007 | 621 | 0.060 |
Why?
|
| GAP-43 Protein | 1 | 2002 | 1 | 0.050 |
Why?
|
| Telencephalon | 1 | 2002 | 6 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2002 | 30 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2002 | 134 | 0.050 |
Why?
|
| Cognition | 1 | 2005 | 512 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 173 | 0.050 |
Why?
|
| Adiposity | 2 | 2011 | 88 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2019 | 10 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 2790 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 317 | 0.040 |
Why?
|
| Body Weight | 2 | 2011 | 554 | 0.040 |
Why?
|
| Benzoxazines | 1 | 2018 | 20 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2018 | 47 | 0.040 |
Why?
|
| Morpholines | 1 | 2018 | 79 | 0.040 |
Why?
|
| Fluorescence | 1 | 2018 | 104 | 0.040 |
Why?
|
| Niclosamide | 1 | 2017 | 2 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 231 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 191 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 148 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 381 | 0.030 |
Why?
|
| Protein Folding | 1 | 2014 | 82 | 0.030 |
Why?
|
| Humans | 3 | 2021 | 68525 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 93 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 70 | 0.030 |
Why?
|
| Peptides | 1 | 2017 | 455 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 258 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1849 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 266 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1640 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1034 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2011 | 16 | 0.030 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2011 | 10 | 0.020 |
Why?
|
| Electroshock | 1 | 2011 | 36 | 0.020 |
Why?
|
| Food Preferences | 1 | 2011 | 46 | 0.020 |
Why?
|
| Swimming | 1 | 2011 | 38 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2010 | 25 | 0.020 |
Why?
|
| Maze Learning | 1 | 2011 | 138 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 184 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 114 | 0.020 |
Why?
|
| Serine | 1 | 2010 | 99 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 311 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.020 |
Why?
|
| tau Proteins | 1 | 2008 | 61 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2008 | 102 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2007 | 23 | 0.020 |
Why?
|
| Fluoxetine | 1 | 2007 | 40 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2007 | 29 | 0.020 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2007 | 53 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 39 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2007 | 59 | 0.020 |
Why?
|
| Axons | 1 | 2007 | 139 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2005 | 10 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2006 | 246 | 0.020 |
Why?
|
| Reinforcement Schedule | 1 | 2005 | 59 | 0.020 |
Why?
|
| Acute Disease | 1 | 2007 | 658 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2005 | 85 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2006 | 222 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 682 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2005 | 213 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2004 | 79 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2005 | 470 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2002 | 27 | 0.010 |
Why?
|
| Septal Nuclei | 1 | 2002 | 31 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 631 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 621 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2002 | 323 | 0.010 |
Why?
|
| Female | 2 | 2017 | 38015 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 1329 | 0.010 |
Why?
|